We have agreements in place with Genentech and Merck
@SalmonKing Merck's agreements with Starpharma were for ADC's .... ask yourself why after 3 years of preclinical research with Starpharma on their ADC's Merck committed up to $22 billion with Daiichi Sankyo's ADC's in October 2023 ? Why would Merck do that if they saw promise with the Starpharma ADC's they were researching ?
Merck have not paid Starpharma one cent in milestone or upfront payments in more than 3 years of signed research agreements (Feb 2021 and Aug 2022) but hey some on here want you to believe the science is so good - so good that Merck are shelling out billions to other biotechs while 'overlooking' their supposed partnership with Starpharma ?
https://www.bloomberg.com/news/arti...s-much-as-22-billion-for-daiichi-cancer-drugs
Merck To Pay as Much as $22 Billion for Daiichi Sankyo’s Cancer Drugs
- Merck will co-develop three ADC cancer drugs with Daiichi
Anything new in upcoming quarterly, page-8
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |